Cargando…

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior

BACKGROUND: Overexpression of CD98hc (SLC3A2) occurs in a variety of cancers and is suspected to contribute to tumor growth. CD98, a heterodimeric transmembrane protein, physically associates with certain integrin β subunit cytoplasmic domains via its heavy chain, CD98hc. CD98hc regulates adhesion-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poettler, Marina, Unseld, Matthias, Braemswig, Kira, Haitel, Andrea, Zielinski, Christoph C, Prager, Gerald W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879186/ https://www.ncbi.nlm.nih.gov/pubmed/24359579 http://dx.doi.org/10.1186/1476-4598-12-169

Ejemplares similares

CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling
por: Féral, Chloé C., et al.
Publicado: (2007)

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior
por: Bianconi, Daniela, et al.
Publicado: (2022)

CD98hc (SLC3A2) regulation of skin homeostasis wanes with age
por: Boulter, Etienne, et al.
Publicado: (2013)

Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
por: Fogelstrand, Per, et al.
Publicado: (2009)

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
por: Prager, Gerald W, et al.
Publicado: (2014)

Integrins in the Spotlight of Cancer
por: Bianconi, Daniela, et al.
Publicado: (2016)

CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
por: Cano-Crespo, Sara, et al.
Publicado: (2019)

Conditional deletion of CD98hc inhibits osteoclast development
por: Tsumura, Hideki, et al.
Publicado: (2015)

LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM
por: Chiduza, George N., et al.
Publicado: (2019)

Extracellular domain of CD98hc is required for early murine development
por: Sato, Yukiyasu, et al.
Publicado: (2011)

Author Correction: CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

CD98hc facilitates B cell proliferation and adaptive humoral immunity
por: Cantor, Joseph, et al.
Publicado: (2009)

Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020)

Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020)

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
por: D’Agostino, Sabrina, et al.
Publicado: (2018)

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice
por: Wuggenig, Philipp, et al.
Publicado: (2020)

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
por: Ichinoe, Masaaki, et al.
Publicado: (2021)

Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
por: Montero, Juan Carlos, et al.
Publicado: (2022)

CD98hc as a marker of radiotherapy-resistant cancer stem cells in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2020)

Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer
por: Bartl, Thomas, et al.
Publicado: (2023)

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
por: Köseer, Ayşe Sedef, et al.
Publicado: (2022)

CD98hc has a pivotal role in maintaining the immuno-barrier integrity of basal layer cells in esophageal epithelium
por: Ye, Hao, et al.
Publicado: (2022)

N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98)
por: Console, Lara, et al.
Publicado: (2022)

β1 integrins show specific association with CD98 protein in low density membranes
por: Kolesnikova, Tatiana V, et al.
Publicado: (2001)

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer
por: Kieler, Markus, et al.
Publicado: (2017)

Dominant Suppression of β1 Integrin by Ectopic CD98-ICD Inhibits Hepatocellular Carcinoma Progression
por: Wu, Bo, et al.
Publicado: (2016)

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid
por: Kieler, Markus, et al.
Publicado: (2019)

CD98 Increases Renal Epithelial Cell Proliferation by Activating MAPKs
por: Bulus, Nada, et al.
Publicado: (2012)

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment
por: Bianconi, Daniela, et al.
Publicado: (2018)

Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT
por: Unseld, Matthias, et al.
Publicado: (2018)

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel
por: Bianconi, Daniela, et al.
Publicado: (2017)

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients
por: Bianconi, Daniela, et al.
Publicado: (2015)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

UNC-98 links an integrin-associated complex to thick filaments in Caenorhabditis elegans muscle
por: Miller, Rachel K., et al.
Publicado: (2006)

Investigation of the Gamow-Teller decay of $^{98}$Cd
por: Barden, R, et al.
Publicado: (1987)

Investigation of the Gamow-Teller decay of $^{98}$Cd
por: Barden, R, et al.
Publicado: (1987)

Antitumor activity of an anti‐CD98 antibody
por: Hayes, Gregory M., et al.
Publicado: (2015)

Phosphorylation but Not Oligomerization Drives the Accumulation of Tau with Nucleoporin Nup98
por: Diez, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34uin3ffk45fspq1pbvmohqneu